fda glp-1 compounding warning september 2025 and Novo Nordisk Warned of Telehealth Takedown. What's Next? FDA takes aim at telehealth

The disappearing sperms: analysis of reports published between 1980 and 2015

Orforglipron, under the brand name Foundayo, received FDA approval on April 1

Pigmented lesions of the oral cavity A brief review

These states cannot be transformed on Washingtons timetable, and Trumps men in the region will not bear the costs of trying

The Study: Real-World Weight Loss Outcomes Researchers analyzed data from over 50,000 adults with obesity: 38,545 patients received a GLP-1 medication such as semaglutide or tirzepatide 12,540 patients underwent bariatric surgery, primarily gastric bypass or sleeve gastrectomy Key Findings : Surgery patients lost an average of 24% of their body weight over two years about 58 pounds